Product logins

Find logins to all Clarivate products below.


The increasing emphasis on evidence-based practice in the US health care landscape has limited the growth of several key ENT device segments. However, continued innovation, particularly in alternative treatments such as drug-eluting sinus stents and balloon Eustachian tube dilation, will fuel overall expansion of the ENT device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Deep Venous Disease Treatment Devices | Market Insights | Global | 2020
The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments,…
Report
Peripheral Vascular Devices | Market Insights | Japan | 2020
The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and …
Report
Interventional Cardiology Devices | Market Insights | US | 2020
The US IC device market will continue to be negatively affected by policies that contribute to declining ASPs, such as Medicare coverage for low-complexity catheterization procedures performed…
Report
Hernia Repair Devices | Market Insights | Global | 2020
The global hernia repair device market will be driven by rising hernia repair volumes as well as the increasing use of tension-free techniques. The growing use of laparoscopy in tension-free…
Report
Heart Valve Devices | Market Insights | Japan | 2020
The Japanese heart valve device market is large and expanding, with growth being driven primarily by the rapid adoption of THV devices and an aging population in this country. Additionally, as…